Occurrence of Z-drugs, benzodiazepines, and ketamine in wastewater in the United States and Mexico during the Covid-19 pandemic

S Adhikari, R Kumar, EM Driver, DA Bowes… - Science of the Total …, 2023 - Elsevier
Z-drugs, benzodiazepines and ketamine are classes of psychotropic drugs prescribed for
treating anxiety, sleep disorders and depression with known side effects including an …

“Stabilise-reduce, stabilise-reduce”: A survey of the common practices of deprescribing services and recommendations for future services

RE Cooper, M Ashman, J Lomani, J Moncrieff, A Guy… - Plos one, 2023 - journals.plos.org
Background Public Health England recently called for the establishment of services to help
people to safely stop prescribed drugs associated with dependence and withdrawal …

Should I, can I, dare I? Patients' view on stopping long-term antidepressant use, a qualitative study

E Van Leeuwen, S Anthierens, ML van Driel… - Acta Clinica …, 2022 - Taylor & Francis
Background and aim The rise in long-term antidepressant use is concerning. Long-term
antidepressant (AD) use, much longer than recommended by guidelines, can result in risk of …

When to stop medication in unipolar depression: A systematic review and a meta-analysis of randomized controlled trials

MK Arıkan, R Ilhan, O Pogarell, B Metin - Journal of Affective Disorders, 2023 - Elsevier
Background Currently, there is no clear answer to the question of how long antidepressants
should be continued or when they can be safely discontinued. Methods Pubmed/Medline …

Predictors of medicine-related perceptions towards deprescribing inappropriate medications among older adult outpatients in Jordan: a cross-sectional study

MJ Rababa, A Al Ghazo, AA Hayajneh - BMJ open, 2024 - bmjopen.bmj.com
Objectives To examine the predictors of medicine-related perceptions towards deprescribing
inappropriate medications among older adults in Jordan. Design A cross-sectional …

Surveying over the counter and prescription only medication misuse in treatment services during COVID-19

R Gittins, R Vaziri, I Maidment - Substance Abuse: Research …, 2022 - journals.sagepub.com
Background: A greater understanding of Over the Counter (OTC) and Prescription Only
Medication (POM) misuse amongst adults accessing substance misuse services (SMS) …

A focus on abuse/misuse and withdrawal issues with selective serotonin reuptake inhibitors (SSRIs): analysis of both the European EMA and the US FAERS …

S Chiappini, R Vickers-Smith, A Guirguis, JM Corkery… - Pharmaceuticals, 2022 - mdpi.com
Despite increasing reports, antidepressant (AD) misuse and dependence remain
underestimated issues, possibly due to limited epidemiological and pharmacovigilance …

A comparison of opioid prescription trends in England and the United States from 2008 to 2020

T Moncrieff, J Moncrieff - International Journal of Risk & Safety …, 2023 - content.iospress.com
BACKGROUND: The prescription opioid epidemic in the United States (US) is well
documented, and recent measures have reduced prescribing rates in that country. Evidence …

In the name of safety: identifying, understanding and stopping low-value safety practices

DB Halligan - 2023 - etheses.whiterose.ac.uk
Low-value healthcare is a widely recognised problem that detracts from the quality of patient
care and places additional pressure on an already over-stretched system. The majority of …

Politicians, experts, and patient representatives call for the UK government to reverse the rate of antidepressant prescribing

J Davies, J Read, D Kruger, N Crisp, N Lamb, M Dixon… - bmj, 2023 - bmj.com
Over the past decade, antidepressant prescriptions have almost doubled in England, rising
from 47.3 million in 2011 to 85.6 million in 2022-23. Over 8.6 million adults in England are …